Genomics England

Berg joins Genomics England to sequence 100,000 genomes

Thursday, October 1, 2015

Berg, a Boston-based biopharmaceutical company, will join an industry collaboration with Genomics England. Formed by British Prime Minister David Cameron, Genomics England is partnering with health companies to accomplish its mission to sequence 100,000 human genomes and create a new genomic medicine service for the National Health Services (NHS) by 2017. The project focuses on patients with rare diseases and six common cancers.

[Read More]

Genomics England calls on the U.K. research community

Wednesday, November 19, 2014

Genomics England is inviting applications to join a new Clinical Interpretation Partnership from U.K. researchers, NHS Clinicians and those in training where they will work on the unique data resource from the 100,000 Genomes Project. The goal of the Genomics England Clinical Interpretation Partnership (GeCIP) is to bring together the best researchers in the U.K., alongside their key international collaborators, to ensure maximized potential to gaining new biological insights into rare inherited diseases, cancers and infectious disease.

[Read More]